107 related articles for article (PubMed ID: 3499333)
1. Immune reactions in patients with type I and with type II diabetes mellitus.
Horváth M; Varsányi M; Jovanovich N; Rózsás Z; Balázsi I
Exp Clin Endocrinol; 1987 Aug; 89(3):354-62. PubMed ID: 3499333
[TBL] [Abstract][Full Text] [Related]
2. T-lymphocyte subsets and their cytotoxic capacity in patients with type I and type II diabetes mellitus.
Horváth M; Varsányi M; Jovanovich N; Rózsás Z; Balázsi I
Allergol Immunopathol (Madr); 1986; 14(5):399-405. PubMed ID: 3492131
[TBL] [Abstract][Full Text] [Related]
3. The effect of azathioprine, cyclosporine A and insulin on the in vitro lymphocyte-mediated cytotoxicity in type I diabetic patients.
Horváth M; Varsányi M; Bándi E; Balázsi I; Romics L
Exp Clin Endocrinol; 1992; 100(3):90-4. PubMed ID: 1305069
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of insulin-dependent diabetes: a role for activated T lymphocytes.
Alviggi L; Johnston C; Hoskins PJ; Tee DE; Pyke DA; Leslie RD; Vergani D
Lancet; 1984 Jul; 2(8393):4-6. PubMed ID: 6145952
[TBL] [Abstract][Full Text] [Related]
5. [Study of lymphocyte subpopulations and the expression of activation markers in diabetes mellitus types 1 and 2].
Salozhin KV; Nasonov EL; Sura VV; Aleksandrova EN; Gracheva LA
Klin Med (Mosk); 1989 Oct; 67(10):118-21. PubMed ID: 2693822
[TBL] [Abstract][Full Text] [Related]
6. Plasma from insulin-dependent diabetics inhibits theophylline sensitive T-lymphocytes demonstrated in E-rosette assay.
Buschard K; Madsbad S; Rygaard J
J Clin Lab Immunol; 1983 Jul; 11(3):123-8. PubMed ID: 6224937
[TBL] [Abstract][Full Text] [Related]
7. The leucocyte migration inhibition test and subpopulations of peripheral lymphocytes in insulin-dependent diabetics.
Nagaoka K; Sakurami T; Nabeya N; Imura H; Kuno S
Endocrinol Jpn; 1979 Feb; 26(1):89-95. PubMed ID: 312198
[TBL] [Abstract][Full Text] [Related]
8. [Detection of antibodies against pancreatic islet cells in clinical practice].
Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
[TBL] [Abstract][Full Text] [Related]
9. Study of T-cell activation in type I diabetic patients and pre-type I diabetic subjects by cytometric analysis: antigen expression defect in vitro.
Giordano C; De Maria R; Todaro M; Stassi G; Mattina A; Richiusa P; Galluzzo G; Pantó F; Galluzzo A
J Clin Immunol; 1993 Jan; 13(1):68-78. PubMed ID: 8095271
[TBL] [Abstract][Full Text] [Related]
10. Circulating class II transplantation antigen-expressing T lymphocytes in children with insulin-dependent diabetes mellitus at diagnosis.
Karlsson-Parra A; Kobbah M; Ewald U; Tuvemo T; Forsum U; Klareskog L
Acta Paediatr Scand; 1988 Jul; 77(4):554-8. PubMed ID: 3293350
[TBL] [Abstract][Full Text] [Related]
11. Analysis of T-lymphocyte subpopulations in juvenile-onset diabetics.
Müller R; Kolb H; Kuschak D; Jörgens V; Gries FA
Clin Exp Immunol; 1980 Jan; 39(1):130-5. PubMed ID: 6966986
[TBL] [Abstract][Full Text] [Related]
12. Immunoregulatory T-lymphocyte subset deficiency in newly diagnosed type 1 (insulin-dependent) diabetes mellitus.
Galluzzo A; Giordano C; Rubino G; Bompiani GD
Diabetologia; 1984 Jun; 26(6):426-30. PubMed ID: 6236119
[TBL] [Abstract][Full Text] [Related]
13. [Importance of estimated value of T-cell activation in insulin-dependent diabetes mellitus].
Zhuk EA; Galenok VA
Ter Arkh; 1999; 71(4):55-7. PubMed ID: 10358866
[TBL] [Abstract][Full Text] [Related]
14. Changes in lymphocyte subsets in children with newly diagnosed type 1 diabetes mellitus.
Kadziela K; Kowalska H; Rymkiewicz-Kluczyńska B; Kowalska M; Miszkurka G; Rybczyńska J; Wasik M; Pańkowska E
J Pediatr Endocrinol Metab; 2003 Feb; 16(2):185-91. PubMed ID: 12713255
[TBL] [Abstract][Full Text] [Related]
15. Lymphocyte subset abnormalities, autoantibodies and their relationship with HLA DR types in children with type 1 (insulin-dependent) diabetes and their first degree relatives.
Peakman M; Warnock T; Vats A; McNab GL; Underhill J; Donaldson PT; Vergani D
Diabetologia; 1994 Feb; 37(2):155-65. PubMed ID: 8163049
[TBL] [Abstract][Full Text] [Related]
16. Lymphocyte subsets and immune complexes in long-standing diabetic patients: relation with the presence of microangiopathy.
Andreani D; Di Mario U; Zuccarini O; Franco M; Sensi M; Iavicoli M; Pozzilli P
Immunol Lett; 1984; 8(1):17-21. PubMed ID: 6611302
[TBL] [Abstract][Full Text] [Related]
17. Characterization of anti-islet cytotoxic human T-cell clones from patients with type 1 diabetes mellitus.
Sobel DO; Creswell K
Autoimmunity; 2006 Jun; 39(4):323-32. PubMed ID: 16891221
[TBL] [Abstract][Full Text] [Related]
18. Beta-cell cytoadherent lymphocytes in some subjects at risk for type 1 (insulin-dependent) diabetes: progression to diabetes within 2 years.
Bardet S; Rohmer V; Maugendre D; Valentin A; Gallois Y; Stetieh H; Marre M; Allannic H; Charbonnel B; Sai P
J Clin Endocrinol Metab; 1990 Nov; 71(5):1310-7. PubMed ID: 2146283
[TBL] [Abstract][Full Text] [Related]
19. Persistent activation of CD8+ T-cells characterizes prediabetic twins.
Peakman M; Leslie RD; Alviggi L; Hawa M; Vergani D
Diabetes Care; 1996 Nov; 19(11):1177-84. PubMed ID: 8908376
[TBL] [Abstract][Full Text] [Related]
20. Abnormal lymphocyte subsets in Kuwaiti patients with type-1 insulin-dependent diabetes mellitus and their first-degree relatives.
Kaaba SA; Al-Harbi SA
Immunol Lett; 1995 Sep; 47(3):209-13. PubMed ID: 8747721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
